Skip to main content
. 2023 Jun 2;5(2):lqad048. doi: 10.1093/nargab/lqad048

Figure 5.

Figure 5.

Results of the decomposition of real cfDNA data. (A) Estimated proportions of skeletal muscle cfDNA in ALS patients (n = 4) and a control group (n = 4). (B) Estimated proportions of placenta cfDNA in healthy pregnant women (n = 8) in their first and third trimester. (C) Estimated proportions of placenta cfDNA in healthy pregnant women (n = 8) and pregnant women with GD (n = 7) in the first trimester of their pregnancies.